Stocks
Arrowhead Pharmaceuticals (ARWR) FCF conversion US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | 5 years average | |||
| FCF conversion, % | -111.4% | 116.4% | 188.2% | 107.6% | 95.2% | 37.8% | |||
| Changes by years, y/y, % | -235pp | +228pp | +72pp | -81pp | -12pp | +79% | |||
Arrowhead Pharmaceuticals. FCF conversion, %
Arrowhead Pharmaceuticals. FCF conversion, changes, pp
Arrowhead Pharmaceuticals (ARWR) FCF conversion US GAAP (quarter values) |
||||||||
| FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | FY2026Q3 | LTM ? | |||
| FCF conversion, % | 105.8% | 20.3% | 19.8% | -76.3% | 117.5% | 37.8% | ||
| Changes by years, y/y, % | +27pp | -85pp | -84pp | -191pp | +12pp | |||
| Changes by quarters, q/q, % | -9pp | -86pp | 0pp | -96pp | +194pp | |||
